01502nam a2200253 4500 384316 929168063X 384316 20070531d1999 y0pory50 ba eng Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs European Monitoring Centre for Drugs and Drug Addiction, EMCDDA Luxembourg Office for Official Publications of the European Communities 1999 94 p. 21 cm Foreword. Abbreviations. Introduction. Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs. Joint action concerning the information exchange, risk assessment and the control of new synthetic drugs. EMCDDA-EDU progress report on the joint action on new synthetic drugs. The pharmacotoxicology and neuropsychology of N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB). Sociological and criminological evidence on the risks of MBDB. Public health risks of MBDB: epidemiological evidence. References. Participants in the risk-assessment process. PREVENÇÃO DA TOXICODEPENDÊNCIA 103892 RELATÓRIO 410454 DROGA SINTÉTICA 320915 COOPERAÇÃO INTERNACIONAL 229150 OEDT 321506 EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION 351987 Oferta 0 PJ_19_000000000000000_D_87 2022-06-06 PJ28088 414207 PJ PJ PJ128088 PJ19.D.87 2022-06-06 0 MO Oferta